XML 22 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Income Statement [Abstract]    
Net sales $ 16,831,477 $ 10,804,214
Cost of sales 12,346,712 7,680,290
Gross profit 4,484,765 3,123,924
Operating expenses:    
Selling and marketing expenses 3,536,617 1,881,434
General and administrative expenses 43,424,105 4,629,642
Research and development costs 855,660 339,385
Impairment loss 3,486,599
Transaction costs 5,109,522
Total operating expenses 56,412,503 6,850,461
Loss from operations (51,927,738) (3,726,537)
Other expense (income):    
Amortization of debt discounts 8,150,284 376,506
Loss on extinguishment of debt 7,096,730 3,030,495
Loss on issuance of convertible notes 5,889,369
Gain on change in fair value of derivatives (18,557,184) (1,939,639)
Gain on change in fair value of contingent consideration (4,847,000)
Interest expense - related party 165,558 608,668
Interest expense, net 1,948,157 12,792,193
Total other (income) expense (154,086) 14,868,223
Loss before income taxes (51,773,652) (18,594,760)
Provision for income taxes
Net loss (51,773,652) (18,594,760)
Other comprehensive gain (loss), net of tax    
Foreign currency translation adjustments 75,132 (15,134)
Total other comprehensive gain (loss), net of tax 75,132 (15,134)
Comprehensive loss $ (51,698,520) $ (18,609,894)
Net loss per share, basic and diluted $ (13.44) $ (6.96)
Weight average number of common shares outstanding, basic and diluted 3,847,672 2,672,304